Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Good morning, ladies and gentlemen, and welcome to Protalix BioTherapeutics Full Year 2025 Financial Results and Business Update Conference Call. As a reminder, this call is being recorded. I will now ...

Vietnam National Petroleum Group engages in the production and distribution of petrochemical products. Its products include chemicals, lubricants, grease, bitumen, liquefied petroleum gas and other ...

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based ...

Regulatory milestone supports advancement of the SOTERIA Phase 2 basket trial evaluating PLX‑200 across multiple lysosomal storage disorders PARAMUS, NJ, March 17, 2026 (GLOBE NEWSWIRE)-- Polaryx ...

Protalix BioTherapeutics reported weaker FY25 results but issued robust FY26 revenue guidance of $78–83 million, well above consensus. PLX’s growth thesis centers on Elfabrio’s EU approval and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

PLX-200 is an orally available compound comprised of gemfibrozil, an FDA-approved lipid regulating agent. The company stated that gemfibrozil’s ability to cross the blood-brain barrier has been ...

An integrated mass spectrometry platform enabling automated collision-, electron- and photon-based fragmentation techniques is presented. A deep learning-based model trained to predict spectra across ...

International Business Machines said Tuesday it closed its roughly $11 billion acquisition of the data-streaming company Confluent. The deal, first announced in December, is intended to help ...

Technology synergies between Confluent’s real-time data platform and IBM’s technology portfolio, including watsonx.data, IBM Z and IBM MQ, will provide artificial intelligence applications and agents ...